Would you consider TPO mimetics for chemotherapy induced thrombocytopenia that persists despite dose reductions?
Answer from: at Academic Institution
The reported evidence on using a TPO-RA in chemotherapy-induced thrombocytopenia (CIT) is complicated but this seems like a situation where it is worth trying a TPO-RA. Repeated dose reduction and/or delay is not good for treatment of a cancer in general. It is very important to individualize the ca...
Comments
Medical Oncologist at Roswell Park Cancer Center Agree. We often get consults from our solid tumor ...
Agree. We often get consults from our solid tumor ...